Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
No Data
LQDA Transcript
Liquidia Corporation (LQDA) Q4 2025 Earnings Call Transcript
Positive3-5
The earnings call summary indicates strong financial performance and optimistic future guidance. YUTREPIA's market share increased significantly, and management is confident in achieving a $1 billion revenue target by 2027. Product differentiation and strategic clinical trials are expected to drive growth. Despite some vague responses, the overall sentiment is positive, with no major concerns raised. The lack of market cap data prevents a more nuanced prediction, but the positive outlook suggests a stock price increase in the short term.
Liquidia Corporation (LQDA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Neutral1-14
Liquidia Corporation (LQDA) Presents at Jefferies London Healthcare Conference 2025 Transcript
Neutral11-19
Liquidia Corporation (LQDA) Q3 2025 Earnings Call Transcript
Positive11-3
The earnings call highlights strong YUTREPIA adoption, positive cash flow, and profitability ahead of schedule. Although there are execution and litigation risks, the company's strategic plans and payer coverage expansion indicate growth potential. The Q&A session shows positive sentiment from analysts, with management addressing concerns effectively. Overall, the positive financial performance and market strategy outweigh the potential risks, suggesting a stock price increase.
LQDA Slides
LQDA Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
